EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis

Li-Qiang Deng, Shi-Ying Li, Tian Xie, Wei-Qiang Zeng, Yu-Yan Wang, Chuan-Jian Shi, Zhang Jin-Fang iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312417 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Li-Qiang Deng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Traditional Chinese Medicine Oncology Center, Shenzhen, Guangdong, P. R. China. Hauptthemen laut MEDLINE: MicroRNAs, Colorectal Neoplasms, Wnt Signaling Pathway, Wnt Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sanming Project of Medicine in Shenzen Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colorectal cancer (CRC) is a prevalent form of malignant tumor, and the current clinical treatments are far from satisfactory. Identifying new therapeutic targets is therefore essential for clinical practices. The long intergenic non-protein coding RNA lincROR has been shown to play a significant role in the tumorigenesis of various cancers. However, the molecular mechanism underlying lincROR-mediated CRC tumorigenesis remains unclear. In the present study, we found that knockdown of lincROR significantly inhibited cell viability in vitro , while its overexpression promoted tumor growth in vivo . Mechanistically, lincROR acted as a miRNA sponge for miR-145, thereby elevating the expression of the target genes WNT2B and WNT10A. The overexpression of WNT2B and WNT10A definitely activated the Wnt/β-catenin pathway, thus led to promoting tumorigenesis in CRC. In summary, our findings identified lincROR as a novel activator of the Wnt/β-catenin pathway by serving as a miRNA sponge for miR-145 and facilitating tumorigenesis, which suggests that lincROR may be a potential therapeutic target for CRC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsColorectal NeoplasmsWnt Signaling PathwayWnt ProteinsGene Expression Regulation, NeoplasticRNA, Long Noncodingbeta CateninCell ProliferationHumansAnimalsMiceCell Line, TumorMice, NudeCarcinogenesisMaleMice, Inbred BALB CFemaleGlycoproteins

Substanzen

MicroRNAsMIRN145 microRNA, humanWNT2B protein, humanWnt ProteinsRNA, Long Noncodingbeta CateninWNT10A protein, humanGlycoproteins

Autor:innen und Institutionen

  • Shenzhen Traditional Chinese Medicine Oncology Center, Shenzhen, Guangdong, P. R. China.
  • Shenzhen Hospital (Futian) of Guangzhou University of Chinese Medicine, Shenzhen, Guangdong, P. R. China.
  • Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, P. R. China.

ORCID-Profile: Zhang Jin-Fang

Förderung

  • National Natural Science Foundation of China
  • Sanming Project of Medicine in Shenzen Municipality

Zitieren

APA

Deng, L. Q., Li, S. Y., Xie, T., Zeng, W. Q., Wang, Y. Y., Shi, C. J., & Jin-Fang, Z. (2024). LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis. PLOS ONE. https://doi.org/10.1371/journal.pone.0312417

Vancouver

Deng LQ, Li SY, Xie T, Zeng WQ, Wang YY, Shi CJ, et al. LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis. PLOS ONE. 2024. doi:10.1371/journal.pone.0312417

BibTeX
@article{Deng2024,
  author = {Deng, Li-Qiang and Li, Shi-Ying and Xie, Tian and Zeng, Wei-Qiang and Wang, Yu-Yan and Shi, Chuan-Jian and Jin-Fang, Zhang},
  title = {LincROR promotes tumor growth of colorectal cancer through the miR-145/WNT2B/WNT10A/Wnt/β-catenin regulatory axis},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312417}
}
Kostenlos starten →